Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.06 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |